They have the same active ingredients—but experts say there are some key factors that set these medications apart at the pharmacy counter. One of the biggest is cost. An employee inspects medications ...

In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...

New Delhi: Swiss drugmaker Roche has moved the Supreme Court, seeking to restrain Natco Pharma from selling the generic version of its life-saving spinal muscular atrophy (SMA) drug Risdiplam in India ...

New York Times Coverage Avoids the Third Rails of Sex Trafficking It Is Time to Be Done with Shutdowns Pro-lifers were disturbed when news broke of the FDA’s approval of a generic form of the ...

Panaji: India is emerging as the pharmacy of the world through generics, said former director of Central Drug Research Institute (CDRI), Lucknow, Dr Madhu Dikshit. Speaking on the topic ‘From ancient ...

Esperion has entered into a settlement agreement with Dr. Reddy’s to resolve the patent litigation in response to Dr. Reddy’s seeking approval to market a generic version of Nexletol and Nexlizet ...

As a writer for Forbes Home since 2021, Emily specializes in writing about home warranties, solar installations, car transportation and moving companies. With a background in journalism and experience ...

This Safety Report describes an approach for assessing doses to members of the public as part of an environmental impact analysis of predictive radioactive discharges. This is achieved by using ...

Tryptophan is an amino acid. Amino acids are molecules that your body uses to make proteins, which help you to: Tryptophan plays a part in many aspects of your health. For instance, it helps keep your ...

You'd think it would be enough for filmmaker James Wan to have two hugely successful horror franchises under his belt with Saw and Insidious (both co-created with writing partner Leigh Whannell). But ...

How can the UK accelerate medical innovation at a time when health systems are under strain and investment is slipping away? That question dominated conversations at the recent PharmaTech Integrates ...